Therefore, in the present study, the expression of SOD, MDA and NF-κB were used as indicators to investigate the mechanism(s) of DSSG in preventing and treating NAFLD. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.